LanthaScreen™ TR-FRET PPAR alpha Coactivator Assay Kit, goat
Product Image

LanthaScreen™ TR-FRET PPAR alpha Coactivator Assay Kit, goat

Este kit contiene anticuerpo Tb-anti-GST de cabra; los otros componentes del kit son los mismos que los del kit A15133:ElMás información
Have Questions?
Número de catálogoCantidad
PV4684Ensayos de 800 x 20 μL
Número de catálogo PV4684
Precio (CLP)
-
Cantidad:
Ensayos de 800 x 20 μL
Este kit contiene anticuerpo Tb-anti-GST de cabra; los otros componentes del kit son los mismos que los del kit A15133:

El ensayo del coactivador de PPAR (receptor activado por proliferador de peroxisomas) alfa LanthaScreen™ TR-FRET proporciona un método sensible y sólido para la detección de alto rendimiento de los potenciales ligandos de PPAR alfa como agonistas o antagonistas del reclutamiento de coactivadores dependientes de ligandos. El kit utiliza un anticuerpo anti-GST marcado con terbio (Tb), un péptido coactivador marcado con fluoresceína y un dominio recombinante humano de unión a ligando de PPAR alfa (PPAR alfa-LBD) que se etiqueta con glutatión-S-transferasa (GST) en un formato de ensayo homogéneo de mezcla y lectura.

Modo agonista:
Al ejecutar el ensayo del coactivador de PPAR alfa LanthaScreen™ TR-FRET en modo agonista (para identificar compuestos agonistas), se añade PPAR alfa-LBD a los compuestos de ensayo de ligando, seguido de la adición de una mezcla de péptido coactivador de fluoresceína y anticuerpo anti-GST marcado con Tb. Después de un periodo de incubación a temperatura ambiente, se calcula la relación TR-FRET de 520 nm/495 nm y se puede utilizar para determinar la EC50 a partir de una curva dosis-respuesta del compuesto. Basado en la biología de la interacción del péptido alfa-coactivador PPAR, este ligando EC50 es un valor compuesto que representa la cantidad de ligando necesaria para unirse al receptor, efectuar un cambio conformacional y reclutar el péptido coactivador (ver Figura 1).

Modo antagonista:
Cuando el ensayo del coactivador de PPAR alfa LanthaScreen™ TR-FRET se ejecuta en modo antagonista (para identificar compuestos antagonistas), se agrega PPAR alfa-LBD a los compuestos de prueba de ligando, seguido de la adición de una mezcla de agonista, péptido coactivador de fluoresceína y anticuerpo anti-GST marcado con Tb (figura 2). La concentración de agonista utilizada en este modo es la concentración de EC80 determinada por la primera ejecución del ensayo en modo agonista.

Contenido y almacenamiento:
El kit de ensayo del coactivador de PPAR alfa LanthaScreen™ TR-FRET contiene proteína PPAR alfa-LBD (GST), péptido coactivador PGC1a marcado con fluorescencia, anticuerpo anti-GST marcado con Tb y tampones. Almacene los componentes como se indica en el protocolo del ensayo (-80 °C, -20 °C o 4 °C).
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Entrada del ensayoInteracción del corregulador bioquímico
Método de detecciónFluorescente
Para utilizar con (aplicación)Ensayo de interacción de cofactores, TR-FRET
Para utilizar con (equipo)Lector de microplacas
ID de gen (Entrez)5465
LigandoPPAR alfa
EnvasePlaca de 384 pocillos
Tipo de productoKit de ensayo de coactivadores TR-FRET PPAR Alfa
CantidadEnsayos de 800 x 20 μL
Presentación de datosPunto final
Condiciones de envíoHielo seco
Entrada dianaPPARA, PPAR alfa, NR1C1
ConjugadoTb (terbio)
Línea de productosLanthaScreen
Unit SizeEach
Contenido y almacenamiento
Almacenar en congelador ultrafrío (entre - 68 y - 85 °C).

Preguntas frecuentes

How does the LanthaScreen technology compare to other TR-FRET assay formats?

We performed a comparison between the LanthaScreen assay and other commercially available TR-FRET assays from 2 different suppliers for the PKC kinase target. Our data revealed that the assays performed comparably, but that the LanthaScreen assay was simpler to optimize and contained fewer components that required optimization. The LanthaScreen assay is a two component system, whereas the other assay formats utilize a trimolecular mechanism which is more time consuming to optimize and has added costs.

For my kinase assay, can I pre-mix the Tb-Ab and EDTA so that I can stop the kinase assay and begin detection with a single reagent addition?

Yes, this is possible depending on the concentrations of reagents used and the time for which they are mixed. We recommend developing and optimizing the assay by using separate reagent additions, because this method will work under the widest range of conditions. Once the assay is optimized, the performance of the assay using pre-mixed antibody and EDTA can be evaluated. We have successfully developed robust assays in which the antibody and EDTA were pre-mixed and then stored overnight at 4 degrees C prior to use the following day. A loss of signal intensity was observed in this case, however, by using the ratiometric readout, this effect was minimal.

Are the LanthaScreen reagents stable to interference from Mg2+, Mn2+, and EDTA?

The chelate is completely stable to Mg2+. The amount of Mn2+ or EDTA that the chelate can tolerate depends largely on how long they are mixed together and the combination of additives used in the reaction. If a reaction requires either Mg2+ or Mn2+ for activation, it is best to stop the reaction by adding an equimolar amount (or slight excess) of EDTA to chelate the metal ions present. This will then essentially eliminate any interference on the terbium chelate by EDTA or Mn2+. Regardless, when LanthaScreen assays are performed using a ratiometric readout (division of the acceptor signal by the donor signal), any interference caused by Mn2+ or EDTA is largely cancelled out.

What is the optimal and/or maximum distance for a Tb-fluorescein pair?

The Förster radius, the distance at which energy transfer efficiency is half-maximal, is around 50-angstroms for the terbiumÆ fluorescein pair. However, the Förster radius does not give a complete indication of energy transfer efficiency when using long lifetime fluorophores such as terbium chelates. When using terbium chelates, energy transfer efficiency is determined by the distance of closest approach between the donor and acceptor during the excited state lifetime of the donor. In many assay systems, such as those designed using antibodies or peptides, there is a large degree of conformational freedom that allows the donor and acceptor to approach one another, effectively enhancing the FRET signal. Additionally, it is important to note that as the donor/acceptor pair approach one another and the efficiency of energy transfer increases, the fluorescent lifetime decreases to a comparable extent. From a practical standpoint, this means that when energy transfer is extremely efficient, FRET cannot be measured in time-resolved mode (because the energy transfer is complete before the measurement is made). This is another reason why TR-FRET assays based around terbium-labeled antibodies or streptavidin perform so well, because there exist a range of donor/acceptor distances, several of which are optimal for measuring FRET.

How many LanthaScreen assays can I run with a given amount of substrate?

It varies, depending on the concentration of substrate used in the assay. But in general, for the peptide substrates, 1 mg of peptide will run approximately 250,000 wells (10 µL reaction, 200 nM peptide). For Poly GT or GAT, the 1 mL of 30 µM size we sell is approximately 1 mg. With these substrates, 1 mL of 30 µM will run approximately 16,700 wells (10 µL reaction, 200 µM substrate).

20 nmol of our physiological protein substrates is sufficient for approximately 10,000 wells (10 µL reaction, 200 µM substrate).